← Leaderboards
Kathleen W. Scotto
Rutgers Biomedical And Health Sciences
$6,029,613
Attributed
$6,433,664
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $419.2K · FY2006–25$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,666,914 · 6
By mechanism
R01$3,927,821 · 3
TL1$1,899,767 · 1
T32$606,076 · 1
P20$233,250 · 1
Top collaborators
- Antonina Mitrofanova2 shared
- Daniel A Notterman2 shared
Most similar at Rutgers Biomedical And Health Sciences
Same institution · by research overlap
- Monica J Roth$14,970,765
- Tamara Minko$15,557,982
- Shridar Ganesan$8,375,704
- John R. Chan$24,248,523
Others in their field
Top investigators on “Multidrug Resistance”
- Judith S. Currier · University Of California Los Angeles$172,380,836
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$172,380,836
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$103,430,446
- David Alland · Rutgers Biomedical And Health Sciences$25,907,239
- Jian Li · Monash University$18,256,928
- David C Hooper · Massachusetts Eye And Ear Infirmary$16,879,291
Research focus
Multidrug ResistanceProtein IsoformsP GlycoproteinGenetic Promoter ElementInterestNeoplasm /Cancer GeneticsGene Induction /RepressionImmunoprecipitationTranslational ResearchTranscription FactorChromatinLaboratory RabbitHealth SciencesNew JerseyTransfectionAntineoplasticsSouthern BlottingColon NeoplasmsNeuroblastomaHistonesNucleosomesNeoplasm /Cancer PharmacologyBiotechnologyBiometry
Grant awards (25)
NJ ACTS: A Platform for Translational Science in New Jersey:Â CTSA Predoctoral T32 at Rutgers, Biomedical Health Sciences$307,406
T32 · FY2025 · TR · contact PI
NJ ACTS: A Platform for Translational Science in New Jersey:Â CTSA Predoctoral T32 at Rutgers, Biomedical Health Sciences$298,670
T32 · FY2024 · TR · contact PI
NRSA Training$376,007
TL1 · FY2023 · TR · contact PI
NRSA Training$400,310
TL1 · FY2022 · TR · contact PI
NRSA Training$377,615
TL1 · FY2021 · TR · contact PI
NRSA Training$419,175
TL1 · FY2020 · TR · contact PI
NRSA Training$326,660
TL1 · FY2019 · TR · contact PI
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism$170,623
R01 · FY2011 · CA · contact PI
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism$88,134
R01 · FY2011 · CA · contact PI
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism$266,760
R01 · FY2010 · CA · contact PI
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism$266,760
R01 · FY2009 · CA · contact PI
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism$266,760
R01 · FY2008 · CA · contact PI
Caffeine regulates splicing of cancer-related genes: dissecting the mechanism$266,618
R01 · FY2007 · CA · contact PI
NJ Center for Clinical and Translational Sciences$233,250
P20 · FY2006 · RR · contact PI
Novel mode of p53 mediated repression the mdri paradigm$244,913
R01 · FY2004 · CA
The MDR1 enhancesome--its activation and inhibition$222,639
R01 · FY2004 · CA
The MDR1 enhancesome--its activation and inhibition$125,961
R01 · FY2004 · CA
The MDR1 enhancesome--its activation and inhibition$348,600
R01 · FY2003 · CA
Novel mode of p53 mediated repression the mdri paradigm$264,600
R01 · FY2003 · CA
The MDR1 enhancesome--its activation and inhibition$314,985
R01 · FY2002 · CA
Novel mode of p53 mediated repression the mdri paradigm$226,800
R01 · FY2002 · CA
Novel mode of p53 mediated repression the mdri paradigm$231,300
R01 · FY2001 · CA
The MDR1 enhancesome--its activation and inhibition$214,828
R01 · FY2001 · CA
The MDR1 enhancesome--its activation and inhibition$164,264
R01 · FY2001 · CA
TRANSCRIPTIONAL CONTROL OF CLASS I P-GLYCOPROTEIN GENES$243,276
R01 · FY2000 · CA